Victor Valverde-Fuentes
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines.
Journal: Frontiers in cellular and infection microbiology
Published: March 26, 2026
LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.
Journal: Frontiers in cellular and infection microbiology
Published: July 11, 2025
Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations.
Journal: International journal of molecular sciences
Published: January 11, 2025
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
Journal: Frontiers in cellular and infection microbiology
Published: June 10, 2024
A highly-safe live auxotrophic vaccine protecting against disease caused by non-typhoidal Salmonella Typhimurium in mice.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: September 15, 2022
Double Auxotrophy to Improve the Safety of a Live Anti-Pseudomonas aeruginosa Vaccine.
Journal: Vaccines
Published: August 24, 2022
Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia.
Journal: International journal of antimicrobial agents
Published: July 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026